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A genetic analysis of tumour progression in Drosophila identifies the cohesin 1 
complex as a suppressor of individual and collective cell invasion 2 
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Metastasis is the leading cause of death for cancer patients. Consequently it is 28 
imperative that we improve our understanding of the molecular mechanisms that 29 
underlie progression of tumour growth towards malignancy. Advances in genome 30 
characterisation technologies have been very successful in identifying commonly 31 
mutated or misregulated genes in a variety of human cancers. However, the 32 
difficulty in evaluating whether these candidates drive tumour progression remains 33 
a major challenge. Using the genetic amenability of Drosophila melanogaster we 34 
generated tumours with specific genotypes in the living animal and carried out a 35 
detailed systematic loss-of-function analysis to identify conserved genes that 36 
enhance or suppress epithelial tumour progression. This enabled the discovery of 37 
functional cooperative regulators of invasion and the establishment of a network of 38 
conserved invasion suppressors. This includes constituents of the cohesin complex, 39 
whose loss-of-function either promotes individual or collective cell invasion, 40 
depending on the severity of effect on cohesin complex function. 41 
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Introduction 46 
Metastasis is the major cause of mortality in human cancers, yet we know relatively 47 
little about the biology that underlies the important transition to invasive 48 
malignancy [1, 2] and currently few genes have been identified that suppress this 49 
process [3, 4]. Most human cancers are epithelial in origin; consequently cancer cell 50 
invasion, where individual cells or groups of cells break away from the primary 51 
tumour to invade the surrounding tissue, is a key hallmark of tumour progression. 52 
Invasion is highly complex, involving concurrent dramatic changes in cytoskeletal 53 
organisation, cell polarity, cell-cell junctions and focal contacts, as cells within the 54 
developing tumour collectively destroy the normal architecture of the host 55 
epithelium and deregulate the local microenvironment [5]. Understanding and 56 
dissecting the molecular mechanisms that promote tumour progression and cancer 57 
cell invasion will be important for the development of new therapeutic strategies in 58 
our battle against this disease. 59 
 60 
Drosophila melanogaster has become an increasingly important model system in the 61 
study of cancer biology. Conservation of major signalling pathways related to 62 
tumourigenesis and metastasis, coupled with the genetic amenability of this 63 
organism, has directly led to advances in our understanding of this disease [6, 7]. Its 64 
short lifespan and low running costs make the organism particularly amenable to 65 
large scale screens, and there is now a vast array of published literature using the fly 66 
to study cancer [6, 8, 9]. 67 
 68 
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We have developed a novel in vivo system in Drosophila that allows us to study 69 
epithelial cell and tissue morphogenesis in real time [10-13]. This system allows the 70 
shape, dynamics and behaviour of labelled mutant epithelial cells to be followed in 71 
high resolution in the living animal. In this current study, we use this in vivo system 72 
to generate tumours with specific genotypes on the dorsal thorax epithelium of the 73 
fly and to observe tumour cell morphology and behaviour in high spatial and 74 
temporal resolution. Although several large-scale cancer screens have been carried 75 
out in the fly (for example [14-18]) our focus was to image and detail primary 76 
tumour behaviour and progression in the living animal. By combining sophisticated 77 
Drosophila genetic techniques with transgenic RNAi technology we present here a 78 
detailed systematic loss-of-function analysis that has identified novel genes that 79 
enhance or suppress tumour progression in this epithelium. We identify a number of 80 
conserved invasion suppressors that promote tumour cell invasion upon loss of 81 
expression. We further characterise components of the cohesin complex, which we 82 
find to be an important invasion suppressor and show that cohesin loss-of-function 83 
can promote either individual or collective cell invasion, depending on the subunit 84 
that is mutated and the degree of effect on cohesin function. 85 
 86 
Results 87 
We developed an in vivo genetic system in the fly that allows us to: (1) generate a 88 
patch of tissue on the dorsal thorax that is homozygous mutant for a tumour 89 
suppressor, surrounded by wild-type tissue; (2) specifically label the mutant tissue 90 
with GFP:Moe (the actin binding domain of moesin fused to GFP), thereby labelling 91 
the actin cytoskeleton of these cells; (3) overexpress an RNAi transgene to deplete 92 
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expression of a gene of interest specifically within the mutant, labelled tissue. 93 
Coupled with our ability to image this epithelium in the living animal in high 94 
temporal and spatial resolution [13], this system allowed us to conduct a large-scale 95 
genetic screen to identify genes that affect tumour behaviour and tumour 96 
progression in a wide variety of ways. 97 
 98 
Design of an in vivo assay to identify modulators of epithelial tumour 99 
progression 100 
We combined the Flp/FRT system [19] the MARCM technique [20] and Pannier-Gal4 101 
to generate positively marked homozygous mutant clones specifically within the 102 
epithelium of the fly pupal notum (the dorsal thorax). When imaging GFP:Moe 103 
labelled WT clones within the pupal notum (at 20-24h APF [after puparium 104 
formation]) we observed columnar epithelial cells that formed an organised 105 
monolayer on the back of the fly (Figure 1a-a’). Preparatory experiments identified 106 
lethal (2) giant larvae4 homozygous mutant clones (lgl4) as a suitable genetic 107 
background for our screen, as tumours lacking lgl were large, partially multilayered, 108 
and presented a low-level invasive phenotype, representing an ideal scenario for an 109 
enhancer/suppressor screen (Figure 1b-d). Lgl is highly conserved, critical for the 110 
correct maintenance of cell polarity, and has also been found to control tissue 111 
growth and differentiation [21]. Lgl is a member of the scribble polarity complex 112 
(lgl, scribble, dlg) which have been termed ‘neoplastic’ tumour suppressors due to 113 
the fact that mutations in these genes can generate highly disorganised 114 
multilayered tumours that are immortal, fail to differentiate, and show a high 115 
metastatic potential upon transplantation [22, 23]. In addition, expression of 116 
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scribble complex genes has been shown to be lost or downregulated in numerous 117 
types of human cancer [24]. 118 
 119 
Although multilayered, amorphous and invasive overgrowth is observed in lgl, 120 
scribble or dlg mutant tissue, overgrowth is not observed when small mutant clones 121 
are generated, surrounded by WT tissue; here clones are restrained from 122 
overgrowth via a process known as ‘cell competition’. Mutant cells, despite 123 
undergoing excessive cell proliferation, are eliminated from the epithelium by Jun 124 
N-terminal kinase (JNK) pathway-mediated apoptosis [25, 26]. Both scribble and lgl4 125 
mutants have previously been shown to cooperate with oncogenic Notch 126 
overexpression to overcome the effects of cell competition and cause neoplastic 127 
overgrowths within the proliferative epithelial primordia known as the imaginal 128 
discs [25, 27]. We wanted to see whether we could observe a similar cooperative 129 
effect within the pupal notum, which at the developmental stage of our analysis 130 
(20-24h APF), is largely post-mitotic. When generating GFP:Moe-labelled clones of 131 
cells expressing activated Notch (Nintra) in the notum, we observed relatively normal 132 
clones, with no effect on cell shape nor tissue organisation, and with no invasive 133 
characteristics (Figure 1e and i-j). When overexpressing Nintra specifically within lgl4 134 
clones however, we observed a strong cooperative effect – these clones showed 135 
strong hyperproliferation, with increased levels of cell division, loss of normal 136 
epithelial architecture, and with increased invasion when compared to lgl4 alone 137 
(Figure 1f-j). We therefore had generated an in vivo system that would allow us to 138 
identify mutations that work cooperatively with lgl4 to promote tumour progression. 139 
 140 
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Pilot screen 141 
During an initial pilot screen, candidate genes previously implicated in cancer were 142 
studied. These genes were well characterised and therefore were very likely to 143 
present a phenotype. Also included were negative controls, i.e. RNAi lines to genes 144 
that are not normally expressed in this tissue. We used transgenic UAS-RNAi lines, 145 
which together with pannier-Gal4 and MARCM, allowed us to restrict gene 146 
knockdown to lgl4 mutant tissue on the notum of the fly (Figure 2a). We used RNAi 147 
lines from two near genome-wide RNAi libraries (VDRC, Austria and NIG, Japan) 148 
and where possible used two independent RNAi transgenes to knock down gene 149 
expression for each gene. In total, the pilot consisted of 67 RNAi lines targeting 46 150 
well-known genes (see Table S1 for a list of pilot genes). These candidates included 151 
various oncogenes, tumour suppressor genes, MMPs, and regulators of cell 152 
morphogenesis, with a range of biological functions (Figure 2b).  153 
 154 
We observed a wide range of phenotypes in the pilot screen including 155 
hyperproliferation, multilayering, invasion, and effects on subcellular structures 156 
(junctions, microvilli, basal protrusions; Figure 2c-k). Negative controls failed to 157 
generate significant phenotypes. We saw a range of expected phenotypes, for 158 
example: increased clonal coverage following RNAi of the known tumour 159 
suppressor, Tsc1 (a negative regulator of Tor signalling); reduced clonal coverage 160 
following RNAi of a known promoter of the cell cycle, tkv (promotes Dpp signalling); 161 
increased multilayering following RNAi of the polarity determinants scrib, expanded 162 
and dlg; smaller apices following RNAi of Cdc42, as has been observed previously 163 
[10] (Table S1).  164 
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 165 
Following the successful completion of the pilot screen, we went on to screen a total 166 
of 764 RNAi lines corresponding to 497 individual genes. Recent advances in 167 
genome characterisation technologies have uncovered a plethora of candidate 168 
genes across numerous tumour types that have been found to be commonly 169 
mutated or misregulated in human cancers [28-30]. However, other than being 170 
implicated by these new technologies, many are completely uncharacterised. By 171 
screening Drosophila orthologues of these previously implicated cancer genes we 172 
sought to determine which of these genes affect tumour behaviour and drive 173 
tumour progression in our system.174 
** This site is not yet publicly available.  
To access the site go to: 
https://flycancerscreen.nottingham.ac.uk/wp-admin and use the following login details:  
Username: reviewer; Password: flycancerscr33n 
Click on the Fly Cancer Screen link in the top left menu to access the site. 
 
9 
Systematic high-throughput scoring and quality control 175 
We generated a database, whereby we could systematically score specific aspects 176 
of tumour behaviour, allowing us to record an extremely detailed analysis of how 177 
each gene knockdown affected tumour behaviour (see Table S1 for full database). 178 
This database consists of 33 phenotypic categories where each animal with lgl4 + 179 
RNAi knockdown clones is scored relative to animals with lgl4 clones alone. Each 180 
category describes an aspect of tumour behaviour. Categories include clone size 181 
and shape, number of dividing cells, number of invading cells, apex size, junction 182 
defects, cytoskeletal defects, multilayering etc. The scoring system we employed 183 
reflected the fact that gene knockdown could either positively or negatively affect 184 
specific aspects of tumour behaviour (Figure S1). A minimum of 5 animals were 185 
analysed per gene knockdown and each animal was scored blind by two 186 
researchers. An online searchable database with all results from the screen, 187 
including all high-resolution images for each RNAi line, is available at 188 
https://flycancerscreen.nottingham.ac.uk (*see footnote below*) 189 
 190 
To verify that our high throughput qualitative scoring system gave meaningful 191 
results that represented real changes in tumour behaviour, we performed a careful 192 
quantitative analysis on a selection of genes chosen at random for categories that 193 
were amenable to a simple quantitative analysis. As shown in Figure S2a-d, a strong 194 
positive correlation was observed for all categories measured (0.91 – 0.97, 195 
Spearman correlation test).196 
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 197 
To further evaluate the quality of our dataset, we asked whether two independently 198 
generated RNAi lines targeting the same gene produced similar phenotypes. We 199 
compared scores across categories for each pair of RNAi lines and found that, of the 200 
256 genes that were targeted by two independent RNAi lines, 224 (87.5%) gave 201 
statistically similar phenotypes (Figure S2e-j; Table S2). 202 
 203 
Identification of genes that affect tumour behaviour 204 
We used an unbiased approach to identify candidate genes that increase or 205 
decrease specific aspects of tumour progression in our system. We calculated a 206 
mean score for each of the 764 RNAi lines across each of the 33 phenotypic 207 
categories (see https://flycancerscreen.nottingham.ac.uk). Using these averages, 208 
we determined the distribution of scores for all 33 categories. Genes with a mean 209 
score above or below the interquartile range from the median were selected as 210 
genes of interest. For categories with a two-tailed distribution we were able to 211 
identify genes that when knocked down, either positively or negatively regulate a 212 
specific aspect of tumour behaviour. For example, using this methodology we 213 
identified 66 RNAi lines that promote, and 49 RNAi lines that inhibit cancer cell 214 
invasion (mean scores range from +0.73 to +1.5, and -0.55 to -1.2, respectively). See 215 
Table S3 for a full list of hits for all categories. 216 
 217 
In order to identify genes that regulate similar or related cell behaviours, we 218 
clustered RNAi lines based on phenotypes presented across all categories. This 219 
resulted in the identification of ten phenotypic clusters (Figure 3a). Analysis of the 220 
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hierarchical clustering revealed, for example, that Cluster 8 shows decreased clonal 221 
tissue and increased tissue multilayering and cell body rounding (Figure 3a).  Gene 222 
ontology (GO) term analysis shows enrichment in junction assembly, cell adhesion, 223 
cell differentiation and fate specification factors (Table S4). A more general 224 
categorisation of gene function reveals an increase in apicobasal polarity and cell-225 
adhesion factors (Figure S3). Therefore, Cluster 8 includes factors that are crucial to 226 
the maintenance of an ordered, monolayered and polarised epithelium. Thus, 227 
cluster analysis reveals groups of genes with similar overall phenotypes that may 228 
share similar or related molecular functions. Within these groups lie several 229 
uncharacterised genes that we can classify as novel tumour suppressors.  230 
 231 
We additionally clustered categories based on phenotypes presented across all 232 
RNAi lines and identified three distinct category clusters (Figure 3b). Categories that 233 
clustered together included those related to (A) actin cytoskeleton regulation, (B) 234 
invasion and multilayering, and (C) cell proliferation and cell and tissue morphology. 235 
We were particularly interested in the identification of novel genes that promote 236 
cancer cell invasion. Interaction networks have become a powerful tool to identify 237 
novel disease-associated genes [31]. To generate a functionally validated interaction 238 
map of invasive genes, we combined all hits in three categories that clustered 239 
strongly together (Figure 3b): invasion, multilayering and cell body rounding. For 240 
each gene, we searched for physical or genetic interactions, validated by 241 
experimental data, including yeast two-hybrid, co-immunoprecipitation, and other 242 
interaction data from various databases (see Methods). We maintained interactions 243 
only between hit genes from these categories, together with lethals and ‘linker 244 
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genes’, which linked hit genes from our screen by one interaction (Figure 4). The 245 
resulting network includes 321 interactions between 140 genes, 99 of which have 246 
not been previously implicated in cancer cell invasion or migration, including 9 247 
genes that are completely uncharacterised. 248 
 249 
Using MCODE (Molecular Complex Detection) software [32] we found seven 250 
clusters of highly interconnected nodes (Figure 4). Complex 1 comprises core 251 
proteins involved in cytoskeleton organisation, including Rac2, Scar, WASp, Arp2 252 
and mbc. Adhesion proteins highly involved in cancer invasion are present in 253 
Complex 6; Complex 5 is enriched in axon guidance molecules, whilst other 254 
identified complexes are enriched in proteins that have not been previously linked 255 
to cancer cell invasion, such as Complexes 4 and 7. By integrating hits in invasive 256 
categories from our screen, together with protein and genetic interaction data, we 257 
have therefore identified a large number of novel genes that are now implicated in 258 
cancer cell invasion. 259 
 260 
Characterisation of invading cancer cells 261 
With the aim of characterising the behaviour of individual invading cells, we 262 
followed cells within mutant clones over time, prior to, during and post-invasion. 263 
We found, in all genotypes studied, that pre-invasive cells would round up and form 264 
a characteristic actin-rich spot at one side of the cell prior to invasion (Figure 5a, 265 
Movie S1). By calculating the coefficient of determination using Spearman’s rho (rs) 266 
we observed a high to moderate positive correlation between a polarised actin 267 
accumulation and invasion in all genotypes studied, irrespective of whether the 268 
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mutant clones were rarely invasive or highly invasive (Figure 5b-d). The number of 269 
cells presenting this polarised phenotype within the epithelial sheet is therefore an 270 
indicator of invasive potential. 271 
 272 
A major advantage of our in vivo model is that the directionality and speed of 273 
invading cells can be studied and quantified in real time (Figure 5a-i). It was notable 274 
that in many cases, invading cells, although viable, have no directionality to their 275 
migration and randomly move about over a number of hours (Figure 5a, Movie S1). 276 
However in some cases, as in the case of SA1KD, invading cells appear to be very 277 
motile (Figure 5e-i, Movie S2). Single cell tracking of lgl4 and SA1KD invading cells 278 
was performed to determine the X, Y and Z trajectories and to calculate their speed 279 
and directionality. An illustration of representative trajectories is shown in Figure 5f-280 
f’. To determine directionality, the trajectory of each cell was measured over 30 min. 281 
The total number of micrometres travelled was documented (Length in Figure 5g-h) 282 
as well as the distance an invading cell would have travelled if following a straight 283 
line (Displacement in Figure 5g-h). Figure 5h shows a significant increase in length 284 
and displacement for SA1KD cells (41.55µm length, p<0.01; 26.55µm displacement, 285 
p<0.05) when compared to lgl4 cells (16.07µm length; 4.16µm displacement). There 286 
is no significant difference between length and displacement in SA1KD cells, 287 
indicating that their trajectories are directional. Additionally, the speed of migration 288 
for SA1KD cells was 2.7-fold higher (1.46µm/min, p<0.01) when compared to lgl4 289 
invading cells (0.53µm/min; Figure 5i). It also became apparent that those cells that 290 
migrated in a fast, directional fashion did not possess a single actin-rich spot, but 291 
multiple dynamic actin-rich spots (Figure 5e) and quantification of migrating cells 292 
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showed that those cells with multiple spots migrated at a significantly faster rate. 293 
We additionally found that a low proportion of lgl4 invading cells can possess 294 
multiple actin-rich spots, which also migrate in a directional fashion (Figure 5j-k) 295 
indicating that this change in cytoskeletal organisation and behaviour is important 296 
to promote directional migration, irrespective of mutant background. 297 
 298 
When imaging pre-invasive and invading cells in the xz plane, we found that cells 299 
that are still attached to, or within, the epithelial sheet show very limited lateral 300 
movement, and only migrate once they are fully detached from the sheet (Figure 5l-301 
m). We additionally found that invading cells detach from the epithelial sheet more 302 
readily in SA1KD clones than in lgl4 clones, which corresponds with SA1KD clones 303 
being highly invasive, with invading cells that exhibit directional migration (Figure 304 
5n). 305 
 306 
It has previously been shown that WT epithelial cells delaminate from the pupal 307 
notum at early pupal stages, but this delamination is concentrated at the midline 308 
region and is rapidly followed by cell death [33, 34]. This is in stark contrast to the 309 
behaviour of invading cells within highly invasive tumours in our screen, where 310 
invasion is observed irrespective of the clone’s position within the epithelial sheet, 311 
and invading cells do not undergo immediate cell death (we have imaged invading 312 
cells for up to 2-hours without observing cell death; for example see Figure 5a and 313 
Movie S1). To specifically test for the viability of invading cells within highly invasive 314 
tumours, we used the genetically encoded apoptosis reporter iCasper [35]. We 315 
expressed iCasper within WT clones, lgl4 clones, and in clones for five strong hits for 316 
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invasion from our screen, namely: lgl4; CG12268KD, lgl4; RhoGAP19DKD, lgl4; 317 
Sema1aKD, lgl4; CG10931KD, lgl4; CacKD. We observed that in four of the five 318 
invasive genotypes tested, a high proportion (70%) of invading cells were iCasper 319 
negative. Only WT, lgl4 alone and lgl4; CG12268KD mutant clones showed a high 320 
proportion of invading cells that were positive for apoptosis (64%; Figure 5o-p).  321 
 322 
Having identified a number of invasion suppressors in our screen, we wanted to test 323 
whether human orthologues of the fly genes within this category would also act in a 324 
similar way. We took a panel of five fly genes that (1) strongly promote invasion 325 
when their expression is knocked down, and (2) have high-confidence, high-scoring 326 
best match human orthologues [36]. Genes included were RhoGAP19D, Rim, S6kII, 327 
CG7379, and shot (their closest human orthologues are ARHGAP23, RIMS2, 328 
RPS6KA3, ING1, DST). We designed siRNAs against these human genes to see if 329 
their loss would lead to similar effects in the MCF7 breast cancer cell line. We used 330 
an in vitro invasion assay to test whether gene KD would promote MCF7 invasion 331 
and/or migration. We found a significant increase in both invasion and migration 332 
following gene KD of RPS6KA3, ING1 and DST, and a significant increase in 333 
migration alone with gene KD of RIMS2 (Figure S4).  334 
 335 
These results provide strong evidence that our novel system can identify regulators 336 
of tumour progression and cancer cell invasion. Results show that in most cases 337 
invading cells are non-apoptotic, and that this model can provide additional insight 338 
on invading cell morphology and behaviour, which can indicate a tumour’s invasive 339 
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potential. Results also suggest that the invasion hits identified in our genetic screen 340 
are likely to have relevance to human disease. 341 
 342 
The cohesin complex is an invasion suppressor 343 
Cohesin is a multi-protein complex that forms a tripartite ring-like structure 344 
consisting of the proteins SMC1, SMC3 and RAD21 [37]. Additionally, RAD21 binds 345 
to a stromalin protein (SA1 or SA2, also known as STAG1 or 2 in humans) [38, 39] 346 
(Figure 6a). Therefore two cohesin complexes can form, with cohesin genomic 347 
distribution subject to a great degree on the SA/STAG protein that binds to the 348 
tripartite ring [40]. Cohesin is evolutionarily conserved, with functional cohesin 349 
complexes found ubiquitously in all Eukaryotic organisms, from yeast to humans 350 
[38, 41]. The cohesin complex is mainly known for its role in sister chromatid 351 
cohesion (SCC) [41] however current understanding of the possible and numerous 352 
roles cohesin may play in tumour initiation and cancer progression is limited [42]. 353 
 354 
Four subunits of the cohesin complex were studied in our genetic screen: SMC1, 355 
SMC3, RAD21 and SA1. Knockdown of these subunits induced significant 356 
cytoskeletal changes to lgl4 tumours, including increased multilayering, cell body 357 
rounding and apex defects. Additionally, SA1KD significantly enhanced the lgl4 358 
invasive phenotype, with other cohesin subunits having no effect on invasion 359 
(Figure 6b-f). We next knocked down the expression of specific cohesin subunits in 360 
WT clones and found that SA1 and SA2KD strongly promoted invasion even in the 361 
absence of the lgl4 mutation, whilst the other subunits did not; all subunits however 362 
promoted multilayering (Figure 6g-i). Using iCasper we also saw that a high 363 
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proportion of invading cells evaded apoptosis (Figure 6j-l) and as shown earlier, 364 
showed fast directional migration (Figure 5e-k; Movie S2). 365 
 366 
Our screen identified cohesin subunits as affecting epithelial architecture, cell 367 
shape, and in the case of SA subunits, promoting frequent cell delamination. These 368 
phenotypes therefore implicate effects on adhesion, polarity and actin regulation as 369 
possible underlying influences on the observed cell behaviour. We investigated cell-370 
cell adhesion and polarity using antibodies to proteins that localise to the adherens 371 
junction (AJ), septate junction (SJ) and the sub-apical region. We generated SA1 and 372 
SA2KD clones and directly compared junction composition inside and outside the 373 
clones within the same tissue. A significant reduction in the cortical localisation of E-374 
cadherin, α-catenin, β-catenin and FasIII was observed at the junctional level in both 375 
SA1 and SA2KD clones, when compared to the surrounding wild type tissue, with 376 
evidence of junctional breaks, ectopic structures (puncta, tubules) and 377 
mislocalisation of junction components (Figure 6m-p), which are phenotypes that 378 
are commonly observed when junctional integrity is compromised [10]. In contrast, 379 
KD had no effect on the polarity proteins investigated (dlg and aPKC; Figure S5). 380 
These results suggest that SA1 and SA2 act as invasion suppressors in part through 381 
the correct localisation of junction determinants, thereby maintaining cell-cell 382 
junction integrity. 383 
 384 
To determine if the role of SA1 and SA2 as invasion suppressors is conserved, we 385 
next studied the effect that the loss of their human orthologues, STAG1 and STAG2, 386 
would have on MCF7 cell invasion and migration using an in vitro invasion assay. 387 
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Loss of function (LOF) mutations of STAG2 are significantly elevated in metastatic 388 
breast cancer tumours when compared to lower grades [43], suggesting that STAG2 389 
has a role in preventing tumour transition to malignancy. STAG2 is also commonly 390 
mutated in several cancer types, including bladder cancer and Ewing’s sarcoma [44, 391 
45].  When analysing each cohesin subunit in turn we found that only STAG1 and 392 
STAG2KD promoted invasion and migration, with the core components of the 393 
tripartite ring failing to affect cell behaviour (Figure S6a-i) thereby mirroring the 394 
effect we see in vivo in the fly (Figure 6g-h). 395 
 396 
Cohesin is known to influence gene expression. It has been shown in yeast and flies 397 
that substantial reductions in cohesin dosage of more than 85% are required to 398 
disrupt cohesion and chromosome segregation, while small to moderate reductions 399 
can affect gene expression [46]. Therefore, the invasive effects that we see in 400 
SA/STAG mutants could be due to changes in the expression of genes that affect 401 
cell-cell junctions and/or the cytoskeleton. Since STAG2 is the most abundant and 402 
most mutated cohesin gene in human cancers we performed a microarray gene 403 
expression analysis, comparing gene expression in MCF-7 cells post STAG2KD with 404 
untreated cells (unt) and with cells treated with non-targeting siRNA (non-T). Out of 405 
21448 genes analysed, the expression of 23 genes was significantly altered as a 406 
result of STAG2KD (p<0.01, FC≥1.5 or FC≤-1.5; Figure S6, Table S5). We additionally 407 
used RT-qPCR on a selection of genes (STAG2, PCDH1, EHD2 and AKR1B10) to 408 
verify the microarray results, with qPCR showing the same or stronger expression 409 
change in all cases (Figure S6n). 410 
 411 
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GO term analysis identified six biological processes that were significantly enriched 412 
within the 23 differentially expressed genes, including cell-cell adhesion, protein 413 
localisation and cell projection organisation (Figure S6o). Additionally, an 414 
interaction network was generated, using the Cytoscape plugin GeneMania, to 415 
display any genetic and physical interactions, verified by experimental data, 416 
between the differentially expressed genes and members of the AJ KEGG pathway 417 
(Figure S6p). 95 interactions between 20 differentially expressed genes and 20 AJ 418 
KEGG pathway genes indicate that the differentially expressed genes in STAG2KD 419 
cells extensively interact with members of the AJ pathway. Furthermore, EHD2 was 420 
significantly downregulated in STAG2KD cells. EHD2 has been linked to E-Cadherin 421 
localisation and expression, and lower EHD2 expression is associated with 422 
metastatic tumours [47, 48]. EHD2 links endocytosis to the actin cytoskeleton [49] 423 
and could therefore be influencing E-Cadherin’s ability to recycle at the junction. 424 
 425 
An additional GO term analysis was performed on differentially expressed genes 426 
found in two studies that depleted STAG2 expression in cell lines of epithelial origin 427 
(MCF10A [40] and HCT116 [50]). Here we found statistically enriched terms 428 
including regulation of cell-cell adhesion, regulation of cellular protein localisation, 429 
regulation of cell-matrix adhesion [40] and positive regulation of cell migration [50]. 430 
 431 
Cohesin loss-of-function induces the formation of a supracellular actomyosin 432 
ring 433 
Although SA1KD, SA2KD and SMC3KD promote multilayering (Figure 6i), at an 434 
apical level they present a phenotype very similar to WT, with cells presenting an 435 
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organised geometric shape (Figure 7a-b, d-e). By contrast, we see a very different 436 
phenotype for three cohesin loss of function genotypes: smc3A  (an ethyl methane 437 
sulfonate induced truncating mutation within smc3, K575term [51, 52]); combined 438 
SA1 + SA2KD; and NipBKD (loss of NippedB prevents cohesin from interacting with 439 
DNA [53]). These mutants induced a highly distinctive phenotype with drastic 440 
cytoskeletal changes, including the formation of a supracellular actin ring (Figure 7c, 441 
f-h), eventually followed by clonal extrusion (Figure S7c). It therefore appears that a 442 
more severe disruption to cohesin function leads to a very different phenotype to 443 
that observed when a single SA subunit is KD. Here individual cell invasion is not 444 
observed, rather apical constriction and basal clonal extrusion occurs, which is likely 445 
to have relevance to the poorly understood process of collective cell invasion in 446 
cancer. We further characterised the phenotype using both GFP:Moe to label actin 447 
and mCherry:spaghetti squash (sqh; the fly orthologue of the regulatory light chain 448 
of non-muscle myosin II). We found that the supracellular ring is enriched with 449 
actomyosin, which induces the invagination of the mutant tissue, forming a ball of 450 
cells with a central lumen (Figure S7b-d). We also found significantly elevated levels 451 
of E-cadherin within smc3A clones (Figure S7d and f), which could also promote 452 
clonal invagination through differential adhesion properties between cell types [54]. 453 
 454 
Long time-lapse movies show that over a number of hours the actomyosin ring 455 
contracts, inducing a basal clonal extrusion from the epithelial sheet (Figure S7c). 456 
Using the caspase sensor, iCasper, we found no significant difference in the levels of 457 
apoptosis in smc3A clones, irrespective of whether the clone was still connected to 458 
the epithelial sheet or had already extruded (Figure S7g). Further, time-lapse 459 
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imaging was performed on extruded clones with little increase in iCasper signal 460 
observed over 1h post-extrusion (Figure S7h), indicating that the basal extrusion of 461 
smc3A clones does not trigger extensive cell death.   462 
 463 
Known mechanisms that trigger apical constriction during development include the 464 
apical localisation of activated Rho1, which recruits and activates myosin II [55]. We 465 
found that Rho1 and Sqh are essential for the determination of smc3A cell 466 
morphology and actin ring formation, since dominant negative Rho (RhoN) and 467 
SqhKD both inhibit actin ring formation and clonal extrusion, whilst 468 
phosphomimetic Sqh (Sqh-EE) significantly increases the prevalence of this 469 
phenotype (Figure 7i-o). 470 
 471 
To better understand the potential mechanism of action of SMC3 in apical 472 
constriction and actin ring formation, an enhancer/suppressor screen of genes 473 
involved in regulating the localisation of myosin II and Rho1 to the apex of the cell 474 
was performed. Six candidate genes were KD and, where possible, overexpressed, 475 
both alone and in combination with the smc3 mutation, to determine if these genes 476 
enhance or rescue the actin ring and clonal extrusion phenotype. Although four 477 
genes promoted actin ring formation in WT clones when overexpressed, only Mad 478 
had any significant effect within smc3A clones. Mad overexpression within smc3A 479 
clones significantly increased the number of actin rings and delaminated clones 480 
(1.196, n=8, p<0.05) when compared to smc3A alone (0.393, n=8), whereas MadKD in 481 
smc3A tissue had the opposite effect (0.196, n=8, p<0.01; Figure 7p-q).  482 
 483 
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Mad is the main effector of the Drosophila Dpp signalling pathway. An increase in 484 
Dpp signalling has been directly implicated in apical constriction and actin ring 485 
formation [56]. Using a phospho-Mad antibody (pMad) we detected a significant 486 
increase in pMad levels in smc3A clones and SA1 + SA2KD clones, specifically when 487 
these clones contained actin rings (Figure 7r-t) suggesting that an increase in Mad 488 
activity is necessary to induce apical constriction in cohesin LOF clones. It therefore 489 
appears that an upregulation of Dpp signalling is a key determinant for the 490 
collective invasion observed in cohesin LOF clones. 491 
 492 
Given the known pleiotropic effects of the cohesin complex (on SCC, homologous 493 
recombination, genome organisation and gene transcription, amongst others) and 494 
given our findings showing that cohesin subunits can regulate individual or 495 
collective cell invasion in an apparent dose-dependent manner, we  studied the 496 
dynamics of chromosomal architecture in dividing cells in vivo. We generated WT, 497 
smc3A, SA1KD, and SA2KD  clones, which were labelled with both GFP:Moe and 498 
Histone:RFP and carried out live imaging of dividing cells within these clones. We 499 
found the vast majority of smc3A mutant cell divisions were defective in 500 
chromosome alignment and/or chromosome separation during metaphase and 501 
anaphase respectively. In contrast, the vast majority of divisions in SA1 and SA2KD 502 
cells appeared normal (Figure S8; Movies S3-S6) adding to the growing body of 503 
evidence to suggest that only a major reduction of cohesin function leads to 504 
cohesion and segregation defects [42]. 505 
 506 
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In summary, this work has: (1) identified numerous genes that affect tumour 507 
behaviour in a wide variety of ways; (2) generated a functionally validated network 508 
of invasion-suppressor genes; (3) identified the cohesin complex as an important 509 
invasion suppressor that can promote individual or collective invasion; (4) 510 




By combining the genetic amenability of Drosophila melanogaster with the power of 515 
RNAi transgenics, we were able to generate tumours with specific genotypes and to 516 
monitor tumour behaviour in the living animal. The in vivo system we have 517 
developed offers a number of significant advantages, and is particularly suitable to 518 
the study of tumour progression and invasion. It enables us to: (1) monitor GFP:Moe 519 
labelled tumours in situ, surrounded by wild-type tissue and the native local 520 
microenvironment; (2) image tumours in high spatial and temporal resolution over a 521 
number of hours or even days post-tumour induction;  (3) knockdown gene 522 
expression specifically within the developing tumour, allowing us to investigate the 523 
tumour promoting potential of numerous genes that would be developmentally 524 
lethal under classic mutation conditions.   525 
 526 
Cancer genomes show extreme heterogeneity, with individual solid organ tumours 527 
possessing on average >50 non-silent mutations in the coding regions of different 528 
genes [57-60]. Breast and colorectal cancers have been found to be the most 529 
heterogeneous, with an average of 84 and 76 mutations/tumour respectively [61, 530 
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62]. Further complexity is evident when considering epigenetic alterations that can 531 
contribute to tumourigenesis and tumour progression [63]. The challenge is to 532 
identify those genes, from the many that have been implicated in human cancer, 533 
which drive cancer progression. We used our in vivo system to investigate a set of 534 
almost 500 genes, whose human orthologues have previously been implicated in 535 
cancer, and have now identified numerous genes that either positively or negatively 536 
regulate specific aspects of tumour behaviour within an epithelium in a living 537 
animal. 538 
 539 
One limitation of the screen, as is the case for any cancer screen, is the fact that the 540 
results presented here describe tumour behaviour within a specific tissue and 541 
anatomical location (the fly notum) and against a specific genetic background (the 542 
underlying mutation being lgl4). In the fly, just as in humans, one would expect 543 
tumours with the same genotype to behave differently in different tissues, and 544 
additionally expect different combinations of mutations to result in different 545 
phenotypes. Despite this, work carried out in the human breast cancer cell line 546 
MCF7 shows that the majority of hits tested give the same phenotypes and thereby 547 
will have relevance to human disease. This is most clearly seen when testing cohesin 548 
subunits in the fly and in MCF7 cells: STAG1 and STAG2 both promote invasion 549 
when their expression is knocked down, whereas other cohesin subunits do not – 550 
recapitulating the effect seen within the fly screen.  551 
 552 
To understand tumour transition to malignancy, and to develop new therapeutic 553 
strategies, it will be key to paint a detailed picture of the complex signalling 554 
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processes that occur during tumour progression. Our database incorporates 33 555 
phenotypic categories and therefore offers a unique starting point to elucidate the 556 
molecular mechanisms of multiple aspects of tumour progression. 557 
 558 
However, our primary focus was invasion, and our screen identified numerous genes 559 
that regulate epithelial cancer cell invasion. We generated a functionally validated 560 
network of invasive genes; GO term analysis of this network identified several terms 561 
that are significantly enriched, indicating processes that are likely to be important 562 
for invasion to take place. This includes adhesion, cytoskeletal remodelling, 563 
signalling and intriguingly many axon guidance molecules. The Slit, Robo and 564 
Semaphorin families have been previously implicated as both tumour and 565 
metastasis suppressors in breast cancer. SLIT/ROBO signalling has been postulated 566 
to prevent invasion by maintaining proper cell-cell adhesion, thereby inhibiting the 567 
detachment of tumour cells [64]. Many other axon guidance genes have been found 568 
to be invasion suppressors in our screen, as have uncharacterised genes that 569 
genetically interact with axon guidance genes, opening up an intriguing avenue of 570 
future research. It is clear that a loss of polarity and a disruption to normal adhesion 571 
are pivotal to promoting the process of invasion. Axon guidance proteins, being 572 
heavily involved in developmental processes that require cell movement, could be 573 
promoting invasive characteristics via these two fundamental processes.  574 
 575 
Our in vivo system is furthermore particularly suited to imaging the invasive 576 
process. Our observation of characteristic cell shape changes (cell rounding and a 577 
polarised actin enrichment) that accompany invasion has been previously reported 578 
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and associated with invasion [65, 66]. However, an important avenue of future 579 
research will be to investigate the morphological and molecular processes that 580 
underlie the differential behaviour between invading cells with and without 581 
directional migration. Cell body rounding would indicate an amoeboid type 582 
migration, but the characteristic blebbing of amoeboid migration is only clearly 583 
obvious in those cells undergoing directional migration. The use of a membrane 584 
(rather than actin-associated) marker together with high resolution microscopy 585 
would help to determine whether the extent of membrane blebbing is an important 586 
attribute for directionality in this system. An additional consideration is the genetic 587 
simplicity of these tumours. It is evident that, in the fly, where there is less 588 
redundancy in key regulatory genes, we are able to generate multilayered, invasive 589 
tumours, with just two key mutations, but for many invasion suppressors further 590 
cooperative mutations are likely to be required to promote directional migration. 591 
ECM composition and the presence/absence of a chemotactic gradient are also 592 
important considerations for directed migration, and will be influencing cell 593 
behaviour here [67].  594 
 595 
Our work on the cohesin complex provides an example of how specific phenotypes 596 
observed in our screen can inform downstream characterisation analyses and 597 
provides further validation that our screen is picking up important regulators of 598 
tumour progression.  599 
 600 
Cohesin was initially identified for its role in SCC in yeast [41, 68] and Xenopus [69], 601 
but has subsequently been found to be involved in homologous recombination-602 
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mediated DNA repair, higher order-chromatin structure and transcriptional 603 
regulation [70-75]. How cohesin performs these multiple roles is not fully 604 
understood, but is thought to be largely due to cohesin’s ability to hold DNA strands 605 
in either trans (during cell division) or cis (generating chromatin loops) [42]. This 606 
wide variety of functions complicates our understanding of how cohesin mutations 607 
may contribute to cancer progression. Inactivating mutations in genes that encode 608 
either the core cohesin subunits, or regulatory proteins that impact on cohesin 609 
function (e.g. PDS5A/B, WAPL, CDCA5, NIPBL, MAU2, etc.) are common in 610 
numerous cancer types, including bladder, melanoma, colorectal, lung, Ewing 611 
sarcoma and myeloid malignancies. Importantly, there is no clear correlation 612 
between the presence of cohesin mutations and aneuploidy in many tumour types, 613 
with recent studies implicating effects on chromatin structure, transcription, DNA 614 
repair and stem cell/progenitor differentiation as important phenotypes that could 615 
promote cancer progression [42, 76]. Although cohesin is essential for cell viability, 616 
mutations are likely to reduce the amount of total functional cohesin within the cell, 617 
which will impact on these diverse cohesin-mediated tasks in different ways, 618 
depending on the subunit that is mutated, the nature of the mutation, and the cell 619 
type affected. Our work shows that, since each specific mutation impacts cohesin 620 
function in different ways, effects on tumour cell behaviour can range from defects 621 
in epithelial architecture, to the promotion of either individual or collective invasion; 622 
the phenotype observed will depend on whether the mutation leads to a 623 




We found loss of cohesin function to induce different phenotypes related to actin 627 
cytoskeleton rearrangement. KD of one subcellular localisation subunit, SA1 or SA2, 628 
increased invasion, multilayering and apex defects. Reduced expression of the core 629 
subunits, SMC1, RAD21 and SMC3, increased multilayering and apex defects, yet 630 
had no effect on invasion. A more severe loss of cohesin function (a LOF smc3 allele, 631 
SA1 + SA2 simultaneous KD or NipBKD) induced clonal extrusion and collective 632 
invasion. Differences in cohesin subunit function (SA1 and SA2 provide subcellular 633 
localisation; SMC1, SMC3 and RAD21 form the core of the ring) [37], isoform 634 
redundancy (SA1/SA2, SMC1A/SMC1B) [38, 77], in combination with the specific 635 
dose required for each subunit to efficiently perform its role in either gene 636 
expression regulation or SCC [78], could be key to understanding the different 637 
effects observed in this study. Several recent studies have shown that individual loss 638 
of SA1 or SA2 has different effects compared to loss of all cohesin [79-81] and that 639 
the two SA subunits are not fully functionally interchangeable [40]. Therefore, loss 640 
of one specific SA subunit will have drastic effects on how cohesin interacts with 641 
chromatin and on gene expression. Our in vivo experiments in the fly and 642 
transcriptomics experiments in vitro suggest that loss of SA1 or SA2 induces single 643 
cell invasion by affecting cohesin mediated gene expression during interphase, with 644 
strong effects on junction stability. Our live cell imaging of SA1 and SA2KD cells 645 
provides further evidence to suggest that aneuploidy is unlikely to make a major 646 
contribution to this phenotype. By contrast, a severe loss of cohesin function due to 647 
a loss of functional SMC3 does lead to chromosomal instability, which ultimately 648 
leads to a misregulation of DPP signalling and increased E-cadherin levels, followed 649 
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by clonal extrusion. This phenotype could be due to a combination of chromosomal 650 
instability, aneuploidy and chromatin rearrangement defects.  651 
 652 
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Figure Legends 679 
Figure 1: lgl4 mutant clones provide an ideal genetic background for an 680 
enhancer/suppressor screen for tumour progression 681 
(a-b) GFP:Moe labelled genetic clones in the dorsal thorax epithelium of living fly 682 
pupae. Clones shown are wild-type (a-a’) or homozygous mutant for the neoplastic 683 
tumour suppressor lgl (b-b’). (c-d) Quantification of average clonal area (c) (n=10 684 
(WT); 18 (lgl4)) and the number of invading cells / the total number of labelled cells 685 
(d) (n= 30 (WT); 41 (lgl4)). Quantification shows lgl4 mutant clones to be similar to 686 
WT clones in size, with a significant increase in the number of invading cells. (e-h) 687 
GFP:Moe labelled genetic clones in the dorsal thorax epithelium of living fly pupae. 688 
Clones shown are overexpressing activated Notch (Nintra; e) or simultaneously 689 
homozygous mutant for lgl4 and overexpressing Nintra (f-h). Highlighted are effects 690 
on cell division (f), invasion (g) and multilayering (h). (i-j) Quantification of the 691 
number of dividing cells (i) and the number of invading cells (j) over the total 692 
number of labelled cells for clones with the genotypes shown (n= 30 (WT); 41(lgl4); 7 693 
(Nintra); 13 (lgl4; Nintra)). Error bars represent ± s.e.m. Student’s T test (e) and Kruskall-694 
Wallis test (f, k-l) were performed to determine statistical significance. Red arrow: 695 
dividing cell; red arrowhead: cell doublet following cytokinesis; white arrows: 696 
invading cells. White scale bar: 50μm; red scale bar: 10μm. 697 
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 698 
Figure 2: Pilot screen identifies several modulators of tumour behaviour. 699 
(a) Schematic illustrating how clones with distinct genotypes were generated on the 700 
back of the fly. The MARCM system was employed to generate mutant clones 701 
specifically within the fly dorsal thorax, through the use of Ubx-Flp. This generated 702 
GFP:Moe labelled lgl4 homozygous mutant clones. RNAi transgene expression, and 703 
therefore gene knockdown, was restricted to the labelled lgl4 mutant tissue. (b) Pie 704 
chart illustrating the range of biological functions from those genes included in the 705 
pilot screen. A: apicobasal polarity; B: cell adhesion; C: cytoskeleton; D: axon 706 
guidance; E: cell cycle; F: gene expression; G: signalling; H: mitochondria; I: others; 707 
J: unknown. (c-k) Examples of phenotypes observed within the pilot screen. In the 708 
pilot screen we observed effects on clonal size (d-e), tissue morphology (e-f), cell 709 
morphology (i and k), and cell behaviour (g-h and j). These are just a few examples 710 
of the many distinct phenotypes that we observed. Arrows: (g) invading cells; (h) 711 
dividing cells; (j) a blebbing dividing cell; (k) very long basal protrusions. 712 
Arrowheads: (h) cell doublet following cytokinesis; (k) long protrusions joining to 713 
form a fascicle. White scale bar: 50μm; red scale bar: 10μm; yellow scale bar: 10μm 714 
in xz plane. 715 
 716 
Figure 3: Clustering analyses identify ten RNAi line clusters and three distinct 717 
phenotypic subgroups  718 
(a) Heat-map representation of supervised clustering of 764 RNAi lines with average 719 
phenotype scores. Each row represents an RNAi line; each column represents a 720 
phenotype category. A priori, the model-based optimal number of K = 10 721 
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(phenotypic clusters) was determined. The clustering of rows and columns are 722 
based on Euclidean distance. Map colours represent row-scaled average scores: blue 723 
indicates the lowest score, light blue indicates an intermediate score, and red 724 
indicates the highest score. Each cluster was analysed with regard to their biological 725 
function by GO enrichment analysis. The most enriched representative GO 726 
categories are shown on the right-hand side of each cluster. (b) Consensus 727 
clustering of average scores of 29 phenotypic categories reveals three distinct 728 
subgroups. Each column represents one phenotype. Heat-maps display consensus 729 
values between pairs of phenotypes by blue shading. High consensus corresponds 730 
to phenotypes that always occur in the same cluster and is shaded dark blue.  731 
 732 
Figure 4: An interaction network of invasion suppressors 733 
Interactions between genes for which knock down enhanced the categories 734 
‘invasion’, ‘multilayering’ and ‘cell body rounding’ are shown. Each circle node 735 
represents a gene. Node colour indicates phenotype observed in the screen: green = 736 
invasion; blue = cell-body rounding; red = multilayering; multi-coloured nodes = 737 
genes that were hits for more than one phenotype; white = lethal; black = ‘linker 738 
genes’, i.e. genes that were not part of the screen, but which connect screen hit 739 
genes by one interaction; nodes with a bold outline = hub genes in this network. 740 
Lines represent interactions: cyan = genetic; orange = protein-protein; green = 741 
interolog. MCODE complexes of highly interconnected genes are outlined in black. 742 
Significantly enriched GO terms are indicated. 743 
 744 
Figure 5: Characterisation of selected invasion suppressors 745 
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(a) An example of a highly invasive mutant clone (genotype: lgl4; CG7379KD) 746 
labelled with GFP:Moe. Highlighted is a pre-invasive cell that rounds up and forms a 747 
characteristic actin-rich spot at one side of the cell prior to invasion (0 mins). The cell 748 
then detaches from the mutant clone and migrates away (arrow). (b-d) Correlation 749 
between the percentage of clonal cells with a polarised actin accumulation and the 750 
percentage of invading cells per animal (n=10 animals/genotype). The two 751 
parameters show a significant correlation, irrespective of whether the mutant 752 
clones were rarely invasive or highly invasive. (e) Stills from a time-lapse showing 753 
the basal surface of a GFP:Moe labelled SA1KD clone. Yellow star marks the initial 754 
location of an invading cell; magenta dot shows the location of the invading cell at 755 
the indicated time. The cell shown has moved 38µm in 8 minutes. (f-f’) 756 
Representative single cell trajectories from lgl4 (orange) and SA1KD invading cells 757 
(blue) shown in xy (f) and xz (f’). Each cell was measured every 3 minutes for 30 758 
minutes. (g) Illustration showing the two trajectories measured for each invading 759 
cell in order to determine directionality. Length (blue) follows the full trajectory of 760 
an invading cell. Displacement (red) measures a straight line from the initial to the 761 
final point. (h) Quantification of length and displacement from lgl4 and SA1KD cells 762 
(n=25 cells from 5 animals/genotype). Cells that have directionality have no 763 
significant difference between length and displacement. (i) Quantification of speed 764 
of migration, showing average µm travelled per minute (n=25 cells from 5 765 
animals/genotype). (j) Quantification of speed of migration (µm/minute) for lgl4 and 766 
SA1KD cells that present either a single actin spot, or multiple actin spots (n=5 767 
cells/group). Those with multiple spots travel faster irrespective of genotype. (k) 768 
SA1KD cells have a significantly higher proportion of invading cells with multiple 769 
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actin spots (n=5 animals/genotype).  (l-m) Orthogonal view of invading cells 770 
showing that cells only migrate once detached from the epithelial sheet (yellow 771 
dot). Red asterisk: pre-invasive cell within sheet; red dot: delaminated cell still 772 
attached to sheet. (n) Quantification of the percentage of pre-invasive cells that 773 
detach from the epithelial sheet and migrate, in WT, lgl4 and SA1KD clones (n=3 774 
animals/genotype). (o-p) iCasper (red) and GFP:Moe (green) labelled mutant clones 775 
(genotypes specified above panels). Arrows highlight invading cells that are iCasper 776 
negative. Four out of the five invasive genotypes tested showed a high proportion of 777 
invading cells that were iCasper negative (quantified in p; n=10 animals/genotype). 778 
Error bars = ± s.e.m. Student’s T test or One-way ANOVA with Dunnett’s post hoc 779 
test for multiple comparisons was performed to determine statistical significance. 780 
Red scale bar: 10μm; yellow scale bar: 10μm in the xz plane. 781 
 782 
Figure 6: SA1 or SA2KD promotes invasion 783 
(a) Somatic cells simultaneously express two different Cohesin rings, differentiated 784 
by the presence of either SA1/STAG1 or SA2/STAG2. (b) Heat map illustrating 785 
qualitative scores given to cohesin subunits included in the genetic screen. A subset 786 
of categories is shown. Red: enhancement of a phenotype; yellow: no phenotype 787 
change; blue: inhibition of a phenotype. (c-f) GFP:moe positively marked lgl4 788 
mutant clones with additional cohesin complex subunit KD, showing invading cells 789 
(arrows; c) and multilayering (e), quantified in (d) and (f); n=5 animals/genotype. 790 
Red dashed line highlights edge of clone. Yellow line shows position of xz slice 791 
shown. (g) Basal confocal slice of GFP:moe positively marked WT, SA1 or SA2KD 792 
clones, highlighting invading cells (arrows). (h-i) Quantification of % invading cells 793 
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(h) and % multilayering (i) following KD of each cohesin subunit, compared to WT. 794 
(j-l) Confocal images of the basal surface of iCasper (red) and GFP:Moe (green) 795 
labelled WT clones (j) and SA2KD clones (k). Arrows highlight invading cells that are 796 
iCasper negative. Quantified in (l): Grey: % invading cells / total number of labelled 797 
cells; blue: % non-apoptotic invading cells / total number of labelled cells; n=50 cells 798 
from 10 animals/genotype. Young WT pupae were used as a control (j) as older WT 799 
animals have little to no invading cells. (m-p) SA1 or SA2KD clones, highlighted by 800 
magenta and cyan dashed lines, respectively, show distrupted E-cadherin (m), 801 
armadillo (n), α catenin (o), fasIII (p), localisation. Arrowheads highlight junctional 802 
breaks. Quantification shows fluorescence intensity at the level of the junction 803 
(n=100 junctions from 10 animals for each genotype). Scale bars: 10μm. Error bars = 804 
± s.e.m. Student’s T test or One-way ANOVA with Dunnett’s post hoc test for 805 
multiple comparisons was performed to determine statistical significance. 806 
 807 
Figure 7: A more severe cohesin LOF induces actin ring formation. 808 
(a-g) GFP:moe positively marked clones (genotype indicated on the bottom left of 809 
panel). Actin rich rings (yellow arrows) were observed in smc3A, SA1 and SA2 810 
simultaneous KD, and NipBKD clones. (h) Quantification of the number of actin 811 
rings per mm2 of clonal tissue. Eight animals were analysed for each genotype. (i-o) 812 
GFP:moe positively marked clones (genotype indicated on the bottom left of panel). 813 
Dominant negative Rho (RhoN) and SqhKD inhibit actin ring formation in smc3A 814 
clones; phosphomimetic Sqh (SqhEE) increases the number of clones with actin 815 
rings. Quantified in (l) and (o) showing the number of actin rings or delaminated 816 
clones per mm2 clonal tissue. Each dot represents one animal. smc3A + RhoV14 817 
 36 
resulted in very small unicellular clones (j) or no clones at all and could not be 818 
quantified. (p-q) Genes involved in apical constriction were either knocked down or 819 
overexpressed in GFP:moe positively marked clones, either on their own (p) or 820 
within smc3A clones (q). Quantification shows the number of actin rings or 821 
delaminated clones per mm2 clonal tissue. Each dot represents 1 animal. (r-s) 822 
GFP:moe labelled smc3A (r) and SA1 + SA2KD (s) clones stained for the active form 823 
of the Dpp signalling effector, phosphorylated Mad (pMad). (t) Quantification of 824 
mean fluorescence intensity from the nuclei of cells within clones, with and without 825 
actin rings, compared to WT tissue within the same animal. 35 nuclei from 7 animals 826 
were measured. Each dot represents one animal. Scale bars: 10μm. Error bars = ± 827 
s.e.m. Statistical analysis: Student’s T test. 828 
 829 
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Supplementary Tables 832 
Table S1: Full database 833 
Table S2: Level of similarity between two RNAi lines targeting the same gene 834 
Table S3: Hits for all categories 835 
Table S4: Lists of genes within clusters and associated GO terms 836 
Table S5: Genes showing a significant change in expression following STAG2KD 837 
in MCF7 cells 838 
 839 
Other Supplementary material 840 
Movie S1: Non-directional migration 841 
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Time-lapse movie of a highly invasive mutant clone (genotype: lgl4; CG7379KD) 842 
labelled with GFP:Moe, showing invading cells with non-directional migration. Time 843 
stamp: top left; scale bar: 10μm. 844 
 845 
Movie S2: Directional migration 846 
Time-lapse movie of an SA1KD clone labelled with GFP:Moe, showing invading cells 847 
with fast, directional migration. Time stamp: top left; scale bar: 10μm. 848 
 849 
Movies S3 – S6: In vivo imaging of cell division 850 
Time-lapse movies of WT (Movie S3), smc3A (Movie S4), SA1KD (Movie S5), and 851 
SA2KD (Movie S6)  clones, labelled with GFP:Moe and Histone:RFP. Time stamp: 852 
bottom right; scale bar: 5μm. 853 
 854 
Cytoscape network file for interaction map of invasive genes 855 
 856 
Cytoscape network file for interaction map of genes misregulated by STAG2KD 857 
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